All In Biotech

Free tool

FAERS Monitor: Antara (Micronized)

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021695 or its brand name (Antara (Micronized), Fenofibrate). Reports on generic versions are filed under their own applications.

Reports

35,836

Serious

24,506

68% of reports

Hospitalization

12,455

Death reported

2,824

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue2,202
  • diarrhoea2,135
  • nausea2,066
  • drug ineffective1,826
  • headache1,583
  • dyspnoea1,561
  • off label use1,420
  • dizziness1,405
  • pain1,399
  • fall1,376
  • asthenia1,331
  • acute kidney injury1,288
  • vomiting1,241
  • arthralgia1,196
  • pruritus1,170

Reports by year received

View as table
YearReports
2004264
2005257
2006404
2007311
2008482
2009553
2010670
2011971
20121,096
20131,084
20141,374
20152,216
20162,581
20172,513
20182,797
20192,729
20202,502
20212,269
20222,233
20232,161
20242,068
20252,335
20261,966

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,018,323 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
acute kidney injurySignal1,2885.04.74,080
fallSignal1,3762.42.31,173
astheniaSignal1,3312.12.0758
diarrhoea2,1351.91.91,006
pruritus1,1701.81.7413
arthralgia1,1961.71.6342
fatigue2,2021.71.6600
dizziness1,4051.71.6371
dyspnoea1,5611.61.5379
vomiting1,2411.61.5247
nausea2,0661.51.5397
headache1,5831.51.4256
pain1,3991.31.3122
off label use1,4201.00.94
drug ineffective1,8260.80.884

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.